COP vs DERM · P/E 19, rev $58.94B vs rev $56.1M
ConocoPhillips (COP) versus Journey Medical Corp (DERM) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported DERM revenue for 2024-12-31 was $56.1M. Net income was -$14.7M. Revenue was down 29.1% from 2023-12-31 to 2024-12-31. DERM currently screens at market cap $163.1M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. DERM currently screens at market cap $163.1M.
Not investment advice. Open the COP and DERM stock pages for the full models.
Not investment advice.